Result Page 2 for Sector: Healthcare Industry: Drug Manufacturers-General Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
All countries
- {{country.name}}
- All countries
- United States (43)
- Argentina (12)
- Austria (13)
- Brazil (13)
- Canada (2)
- Chile (4)
- China (7)
- Finland (2)
- France (2)
- Germany (51)
- Hong Kong (1)
- Hungary (1)
- India (18)
- Italy (1)
- Japan (7)
- Mexico (14)
- Singapore (1)
- South Korea (3)
- Sweden (1)
- Switzerland (5)
- Taiwan (1)
- Turkey (1)
- United Kingdom (15)
All exchanges
- {{item.name}}
- All exchanges
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (39)
- Helsinki (2)
- HKSE (1)
- IOB (15)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (1)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (13)
- SES (1)
- Shanghai (3)
- Shenzhen (4)
- Stockholm (1)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (11)
Healthcare (218)
- {{item.name}}
- All sectors
- Healthcare (218)
Drug Manufacturers-General (218)
- {{item.name}}
- All Industries
- Biotechnology (1697)
- Drug Manufacturers-General (218)
- Drug Manufacturers-Specialty & Generic (955)
- Healthcare Plans (43)
- Medical Care Facilities (421)
- Pharmaceutical Retailers (104)
- Health Information Services (236)
- Medical Devices (671)
- Medical Instruments & Supplies (416)
- Diagnostics & Research (321)
- Medical Distribution (120)
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | Prediction |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | Prediction | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Merck & Co., Inc. MRK.PA | €101.40 110.84 USD |
0
|
€260.61B 284.88B USD | €250.00 273.28 USD | €100.20 109.53 USD | €101.60 111.06 USD | €260.61B 284.88B USD | 21.03 | €4.82 5.27 USD | ||
| Merck & Co., Inc. MRK.MX | MX$1,915.00 113.39 USD |
-0.52
|
MX$4.75T 281.44B USD | MX$80.00 4.74 USD | MX$1,910.00 113.1 USD | MX$1,915.00 113.39 USD | MX$4.75T 281.44B USD | 14.15 | MX$135.33 8.01 USD | ||
| AstraZeneca PLC ZEG.F | €158.30 173.04 USD |
+1.25
|
€245.41B 268.27B USD | €15.00 16.4 USD | €156.65 171.24 USD | €158.30 173.04 USD | €245.41B 268.27B USD | 30.97 | €5.11 5.59 USD | ||
| AstraZeneca PLC ZEGA.F | €78.00 85.26 USD |
-1.89
|
€241.84B 264.37B USD | €7.00 7.65 USD | €78.00 85.26 USD | €78.00 85.26 USD | €241.84B 264.37B USD | 30.46 | €2.56 2.8 USD | ||
| Gilead Sciences, Inc. GILD.BA | ARS 45,540.00 55.39 USD |
-1.39
|
ARS 221.62T 261.96B USD | ARS 257.00 0.3 USD | ARS 46,860.00 55.39 USD | ARS 48,140.00 56.9 USD | ARS 221.62T 261.96B USD | 4.99 | ARS 9.38K 11.08 USD | ||
| Merck & Co., Inc. MRK.SN | $102.40 — |
0
|
$254.16B — | $0.00 — | $102.40 — | $102.40 — | $254.16B — | 13.54 | $7.56 — | ||
| Pfizer Inc. PFE.BA | ARS 9,645.00 11.21 USD |
+2.27
|
ARS 213.97T 252.92B USD | ARS 94.19K 111.33 USD | ARS 9,465.00 11.19 USD | ARS 9,630.00 11.38 USD | ARS 213.97T 252.92B USD | 1.89 | ARS 4.99K 5.9 USD | ||
| Merck & Co., Inc. MRK.VI | €94.70 98.93 USD |
+4.27
|
€227.59B 248.79B USD | €222.00 213.16 USD | €90.20 98.6 USD | €90.60 99.04 USD | €227.59B 248.79B USD | 14.09 | €6.42 7.02 USD | ||
| Merck & Co., Inc. 6MK.DE | €90.20 98.6 USD |
-0.99
|
€226.84B 247.97B USD | €1.38K 1.5K USD | €90.10 98.49 USD | €90.70 99.15 USD | €226.84B 247.97B USD | 14.04 | €6.42 7.02 USD | ||
| Merck & Co., Inc. 6MK.F | €90.30 98.71 USD |
-0.55
|
€225.87B 246.9B USD | €232.00 253.61 USD | €90.30 98.71 USD | €90.40 98.82 USD | €225.87B 246.9B USD | 14.06 | €6.42 7.02 USD | ||
| Novartis AG NOTA.F | €122.00 127.9 USD |
+0.83
|
€224.50B 245.41B USD | €20.00 21.86 USD | €115.50 126.26 USD | €117.00 127.9 USD | €224.50B 245.41B USD | 18.84 | €6.21 6.79 USD | ||
| Amgen Inc. AMGN34.SA | R$63.24 13.37 USD |
+2.21
|
R$994.74B 201.62B USD | R$0.00 0 USD | R$65.96 13.37 USD | R$65.96 13.37 USD | R$994.74B 201.62B USD | 25.76 | R$2.56 0.52 USD | ||
| Amgen Inc. AMGN.MX | MX$5,935.00 351.42 USD |
0
|
MX$3.26T 192.79B USD | MX$2.00 0.12 USD | MX$5,935.00 351.42 USD | MX$5,935.00 351.42 USD | MX$3.26T 192.79B USD | 25.64 | MX$231.47 13.71 USD | ||
| Bristol-Myers Squibb Company BMY.BA | ARS 27,040.00 32.41 USD |
+0.95
|
ARS 160.47T 189.68B USD | ARS 700.00 0.83 USD | ARS 27,400.00 32.39 USD | ARS 27,740.00 32.79 USD | ARS 160.47T 189.68B USD | 6.36 | ARS 4.31K 5.1 USD | ||
| GSK plc GSK.BA | ARS 19,020.00 22.09 USD |
+1.77
|
ARS 150.80T 178.25B USD | ARS 260.00 0.31 USD | ARS 18,690.00 22.09 USD | ARS 19,000.00 22.46 USD | ARS 150.80T 178.25B USD | 14.34 | ARS 1.30K 1.54 USD | ||
| Gilead Sciences, Inc. GILD34.SA | R$327.77 69.72 USD |
+3.16
|
R$855.26B 173.35B USD | R$0.00 0 USD | R$343.98 69.72 USD | R$343.98 69.72 USD | R$855.26B 173.35B USD | 19.19 | R$17.92 3.63 USD | ||
| Amgen Inc. AMGN.VI | €277.80 306.46 USD |
-0.53
|
€150.96B 165.02B USD | €84.00 91.82 USD | €277.95 303.84 USD | €281.00 307.17 USD | €150.96B 165.02B USD | 25.50 | €10.99 12.01 USD | ||
| Amgen Inc. AMG.DE | €280.30 306.41 USD |
-0.51
|
€150.94B 164.99B USD | €655.00 716 USD | €279.00 304.98 USD | €280.75 306.9 USD | €150.94B 164.99B USD | 25.50 | €10.99 12.01 USD | ||
| Amgen Inc. AMG.F | €279.40 305.42 USD |
-1.04
|
€150.45B 164.46B USD | €15.00 16.4 USD | €279.40 305.42 USD | €279.40 305.42 USD | €150.45B 164.46B USD | 25.44 | €10.98 12 USD | ||
| Gilead Sciences, Inc. GILD.MX | MX$2,189.46 131.59 USD |
+0.04
|
MX$2.77T 163.81B USD | MX$3.29K 194.93 USD | MX$2,210.54 130.89 USD | MX$2,222.32 131.59 USD | MX$2.77T 163.81B USD | 19.20 | MX$115.74 6.85 USD | ||
| Pfizer Inc. PFIZ34.SA | R$34.50 6.99 USD |
-0.95
|
R$784.63B 159.03B USD | R$3.83K 776.48 USD | R$34.28 6.95 USD | R$34.99 7.09 USD | R$784.63B 159.03B USD | 14.43 | R$2.39 0.48 USD | ||
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | ||
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | ||
| Pfizer Inc. PFE.MX | MX$450.30 26.66 USD |
+0.17
|
MX$2.56T 151.83B USD | MX$1.35K 80 USD | MX$447.01 26.47 USD | MX$450.30 26.66 USD | MX$2.56T 151.83B USD | 14.62 | MX$30.79 1.82 USD | ||
| Gilead Sciences, Inc. GILD.VI | €103.18 116 USD |
+0.44
|
€132.78B 145.15B USD | €0.00 0 USD | €106.02 115.89 USD | €106.24 116.13 USD | €132.78B 145.15B USD | 19.36 | €5.48 5.99 USD | ||
| Gilead Sciences, Inc. GIS.DE | €106.28 116.18 USD |
+0.32
|
€132.29B 144.61B USD | €10.00 10.93 USD | €106.28 116.18 USD | €106.36 116.27 USD | €132.29B 144.61B USD | 19.35 | €5.49 6 USD | ||
| Gilead Sciences, Inc. GIS.F | €103.32 115.5 USD |
-0.17
|
€131.09B 143.3B USD | €290.00 317.01 USD | €105.66 115.5 USD | €105.88 115.74 USD | €131.09B 143.3B USD | 19.24 | €5.49 6 USD | ||
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$136.83B — | $0.00 — | $110.29 — | $110.29 — | $136.83B — | 17.07 | $6.46 — | ||
| Pfizer Inc. PFE.VI | €21.59 23.28 USD |
+0.56
|
€121.08B 132.35B USD | €0.00 0 USD | €21.26 23.24 USD | €21.30 23.28 USD | €121.08B 132.35B USD | 14.58 | €1.46 1.6 USD | ||
| Pfizer Inc. PFEB.F | €6.85 7.32 USD |
+0.74
|
€120.27B 131.47B USD | €861.00 941.19 USD | €6.70 7.32 USD | €6.70 7.32 USD | €120.27B 131.47B USD | 13.40 | €0.50 0.55 USD | ||
| AstraZeneca PLC AZN.BA | ARS 70,525.00 83.39 USD |
-0.28
|
ARS 109.37T 129.28B USD | ARS 36.00 0.04 USD | ARS 70,550.00 83.39 USD | ARS 71,425.00 84.43 USD | ARS 109.37T 129.28B USD | 8.07 | ARS 8.74K 10.33 USD | ||
| Bristol-Myers Squibb Company BMYB34.SA | R$285.94 60.82 USD |
+0.77
|
R$616.97B 125.05B USD | R$0.00 0 USD | R$300.06 60.82 USD | R$300.06 60.82 USD | R$616.97B 125.05B USD | 18.21 | R$16.47 3.34 USD | ||
| Bristol-Myers Squibb Company BMY.MX | MX$974.26 57.69 USD |
-0.59
|
MX$1.98T 117.44B USD | MX$41.96K 2.48K USD | MX$974.26 57.69 USD | MX$974.26 57.69 USD | MX$1.98T 117.44B USD | 18.30 | MX$53.21 3.15 USD | ||
| GSK plc G1SK34.SA | R$51.44 11 USD |
+0.96
|
R$547.13B 110.89B USD | R$0.00 0 USD | R$54.25 11 USD | R$54.25 11 USD | R$547.13B 110.89B USD | 13.63 | R$3.98 0.81 USD | ||
| Sanofi SNW.F | €80.40 90.75 USD |
+0.79
|
€100.57B 109.94B USD | €746.00 815.48 USD | €82.45 90.13 USD | €83.02 90.75 USD | €100.57B 109.94B USD | 15.84 | €5.24 5.73 USD | ||
| Sanofi SANO.VI | €82.03 90.72 USD |
+0.7
|
€100.53B 109.9B USD | €95.00 34.98 USD | €82.65 90.35 USD | €82.99 90.72 USD | €100.53B 109.9B USD | 15.83 | €5.24 5.73 USD | ||
| Sanofi SNW2.F | €40.80 44.6 USD |
-1.92
|
€98.85B 108.06B USD | €24.00 26.24 USD | €40.80 44.6 USD | €40.80 44.6 USD | €98.85B 108.06B USD | 15.57 | €2.62 2.86 USD | ||
| GSK plc GSKN.MX | MX$864.00 51.16 USD |
0
|
MX$1.77T 104.85B USD | MX$0.00 0 USD | MX$864.00 51.16 USD | MX$864.00 51.16 USD | MX$1.77T 104.85B USD | 13.44 | MX$64.28 3.81 USD | ||
| Bristol-Myers Squibb Company BMYS.VI | €45.67 50.38 USD |
0
|
€93.85B 102.6B USD | €0.00 0 USD | €46.09 50.38 USD | €46.58 50.92 USD | €93.85B 102.6B USD | 18.28 | €2.52 2.75 USD | ||
| Bristol-Myers Squibb Company BRM.DE | €46.00 50.28 USD |
-0.3
|
€93.70B 102.43B USD | €903.00 987.1 USD | €45.90 50.17 USD | €46.20 50.5 USD | €93.70B 102.43B USD | 18.25 | €2.52 2.75 USD | ||
| Bristol-Myers Squibb Company BRM.F | €45.59 49.84 USD |
-1.69
|
€92.81B 101.45B USD | €365.00 398.99 USD | €45.59 49.84 USD | €45.59 49.84 USD | €92.81B 101.45B USD | 18.09 | €2.52 2.75 USD | ||
| GSK GLAXF | $23.00 — |
0
|
$94.16B — | $1.30K — | $23.66 — | $23.71 — | $94.16B — | 12.77 | $1.80 — | ||
| Chugai Pharmaceutical CHGCF | $53.89 — |
+0.54
|
$93.85B — | $100.00 — | $52.42 — | $52.42 — | $93.85B — | 34.99 | $1.54 — | ||
| Chugai Pharmaceutical Co., Ltd. CUP.F | €44.29 48.41 USD |
+0.43
|
€73.67B 80.53B USD | €345.00 377.13 USD | €44.25 48.37 USD | €44.29 48.41 USD | €73.67B 80.53B USD | 33.80 | €1.31 1.43 USD | ||
| Biogen Inc. BIIB.BA | ARS 21,000.00 24.52 USD |
+1.25
|
ARS 37.90T 44.8B USD | ARS 778.00 0.92 USD | ARS 20,680.00 24.44 USD | ARS 20,850.00 24.65 USD | ARS 37.90T 44.8B USD | 1.30 | ARS 15.92K 18.82 USD | ||
| Bayer Aktiengesellschaft BAYZF | $42.91 — |
+3.15
|
$42.94B — | $6.00K — | $43.00 — | $43.00 — | $42.94B — | 0 | -$0.24 — | ||
| Bayer Aktiengesellschaft BAYN.VI | €41.42 40.48 USD |
+1.67
|
€36.39B 39.78B USD | €2.06K 2.25K USD | €36.15 39.52 USD | €37.03 40.48 USD | €36.39B 39.78B USD | 0 | -€0.20 -0.2 USD | ||
| Bayer Aktiengesellschaft BAYER.BD | HUF 16,896.00 39.19 USD |
+0.16
|
HUF 13.94T 38.57B USD | HUF 40.00 0.11 USD | HUF 14,170.00 39.19 USD | HUF 14,170.00 39.19 USD | HUF 13.94T 38.57B USD | 0 | -HUF 77.81 -0.2 USD | ||
| Bayer Aktiengesellschaft BAYA.F | €8.80 9.62 USD |
-0.56
|
€34.58B 37.8B USD | €300.00 327.94 USD | €8.80 9.62 USD | €8.80 9.62 USD | €34.58B 37.8B USD | 0 | -€0.05 -0.05 USD | ||
| Daiichi Sankyo Company, Limited D4S.F | €18.51 20.23 USD |
+0.05
|
€34.26B 37.45B USD | €150.00 163.97 USD | €17.95 19.62 USD | €18.51 20.23 USD | €34.26B 37.45B USD | 22.85 | €0.81 0.89 USD | ||
| Biogen Inc. BIIB34.SA | R$162.56 32.63 USD |
+3.25
|
R$142.28B 28.84B USD | R$4.00 0.81 USD | R$161.00 32.63 USD | R$161.00 32.63 USD | R$142.28B 28.84B USD | 15.92 | R$10.11 2.05 USD | ||
| Otsuka Holdings Co., Ltd. OS1.F | €48.00 52.47 USD |
-1.23
|
€26.22B 28.66B USD | €26.00 28.42 USD | €48.00 52.47 USD | €48.00 52.47 USD | €26.22B 28.66B USD | 11.62 | €4.13 4.51 USD | ||
| Biogen Inc. BIIB.MX | MX$3,125.00 185.04 USD |
0
|
MX$458.44B 27.15B USD | MX$0.00 0 USD | MX$3,125.00 185.04 USD | MX$3,125.00 185.04 USD | MX$458.44B 27.15B USD | 15.89 | MX$196.56 11.64 USD | ||
| Astellas Pharma ALPMF | $13.17 — |
+7.98
|
$26.14B — | $100.00 — | $13.10 — | $13.10 — | $26.14B — | 32.27 | $0.44 — | ||
| Biogen Inc. IDP.F | €150.05 164.02 USD |
+0.13
|
€22.16B 24.22B USD | €90.00 98.38 USD | €150.05 164.02 USD | €150.05 164.02 USD | €22.16B 24.22B USD | 16.09 | €9.32 10.19 USD | ||
| Biogen Inc. BIIB.VI | €150.25 164.24 USD |
-0.23
|
€22.04B 24.09B USD | €0.00 0 USD | €148.95 162.82 USD | €150.60 164.63 USD | €22.04B 24.09B USD | 16.12 | €9.32 10.19 USD | ||
| Biogen Inc. IDP.DE | €149.95 163.92 USD |
-0.4
|
€22.00B 24.05B USD | €154.00 168.34 USD | €147.20 160.91 USD | €149.95 163.92 USD | €22.00B 24.05B USD | 16.08 | €9.32 10.19 USD | ||
| Astellas Pharma Inc. YPH.F | €11.13 12.17 USD |
+0.36
|
€20.51B 22.42B USD | €375.00 409.93 USD | €11.13 12.17 USD | €11.19 12.23 USD | €20.51B 22.42B USD | 29.28 | €0.38 0.42 USD | ||
| Astellas Pharma Inc. YPHA.F | €11.10 12.13 USD |
0
|
€20.48B 22.38B USD | €176.00 192.39 USD | €11.10 12.13 USD | €11.10 12.13 USD | €20.48B 22.38B USD | 29.21 | €0.38 0.42 USD | ||
| Cipla Limited CIPLA.BO | ₹1,463.25 18.04 USD |
+0.18
|
₹1.20T 14.57B USD | ₹21.14K 910.1 USD | ₹1,476.60 17.86 USD | ₹1,496.25 18.1 USD | ₹1.20T 14.57B USD | 22.17 | ₹67.25 0.81 USD | ||
| CSPC Pharmaceutical CHJTF | $0.95 — |
0
|
$11.73B — | $1.76K — | $1.10 — | $1.10 — | $11.73B — | 19.00 | $0.05 — | ||
| CSPC Pharmaceutical Group Limited CVG.F | €0.91 0.99 USD |
-0.96
|
€10.65B 11.64B USD | €2.50K 2.73K USD | €0.91 0.99 USD | €0.91 0.99 USD | €10.65B 11.64B USD | 22.75 | €0.04 0.04 USD | ||
| Orion Oyj ORINF | $81.30 — |
0
|
$11.44B — | $100.00 — | $81.30 — | $81.30 — | $11.44B — | 26.05 | $3.12 — | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €48.50 53.02 USD |
-0.41
|
€9.94B 10.87B USD | €0.00 0 USD | €48.42 52.93 USD | €48.50 53.02 USD | €9.94B 10.87B USD | 25.12 | €1.93 2.11 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €48.22 52.71 USD |
-0.74
|
€9.91B 10.84B USD | €30.00 32.79 USD | €47.98 52.45 USD | €48.26 52.75 USD | €9.91B 10.84B USD | 24.98 | €1.93 2.11 USD | ||
| Orion Oyj ORINY | $36.84 — |
+4.43
|
$10.37B — | $1.00 — | $34.10 — | $34.10 — | $10.37B — | 28.12 | $1.31 — | ||
| Orion Oyj OFK0.F | €31.60 34.54 USD |
0
|
€9.07B 9.92B USD | €100.00 109.31 USD | €31.60 34.54 USD | €31.60 34.54 USD | €9.07B 9.92B USD | 28.21 | €1.12 1.22 USD | ||
| Orion Oyj OFK.F | €63.85 69.8 USD |
+0.63
|
€9.00B 9.84B USD | €7.00 7.65 USD | €63.45 69.36 USD | €63.85 69.8 USD | €9.00B 9.84B USD | 28.63 | €2.23 2.44 USD | ||
| Grifols, S.A. GIFOF | $8.81 — |
0
|
$8.66B — | $4.41K — | $8.18 — | $8.25 — | $8.66B — | 16.95 | $0.52 — | ||
| Grifols, S.A. GIKLY | $6.16 — |
0
|
$8.38B — | $50.00 — | $6.70 — | $6.70 — | $8.38B — | 19.25 | $0.32 — | ||
| Kyowa Kirin KYKOF | $16.54 — |
+4.39
|
$8.29B — | $1.40K — | $16.54 — | $16.54 — | $8.29B — | 33.71 | $0.47 — | ||
| Grifols, S.A. GRF.VI | €10.90 11.92 USD |
-0.91
|
€7.42B 8.11B USD | €0.00 0 USD | €10.90 11.91 USD | €10.95 11.96 USD | €7.42B 8.11B USD | 19.81 | €0.55 0.6 USD | ||
| Grifols, S.A. OZTA.F | €10.88 11.89 USD |
-0.96
|
€7.40B 8.09B USD | €10.68K 11.67K USD | €10.88 11.89 USD | €10.88 11.89 USD | €7.40B 8.09B USD | 19.78 | €0.55 0.6 USD | ||
| Grifols GIFLF | $11.66 — |
0
|
$7.93B — | $500.00 — | $14.00 — | $14.00 — | $7.93B — | 18.21 | $0.64 — | ||
| Grifols, S.A. G0F.F | €5.20 5.68 USD |
-0.95
|
€7.08B 7.74B USD | €160.00 174.9 USD | €5.20 5.68 USD | €5.20 5.68 USD | €7.08B 7.74B USD | 19.25 | €0.27 0.3 USD | ||
| Kyowa Kirin Co., Ltd. KY4.F | €13.40 14.65 USD |
+0.75
|
€7.06B 7.72B USD | €500.00 546.57 USD | €13.40 14.65 USD | €13.40 14.65 USD | €7.06B 7.72B USD | 33.50 | €0.40 0.44 USD | ||
| Abbott India Limited ABBOTINDIA.BO | ₹27,948.50 344.91 USD |
-1.4
|
₹605.80B 7.33B USD | ₹113.00 13.88 USD | ₹28,303.80 342.43 USD | ₹29,073.95 351.75 USD | ₹605.80B 7.33B USD | 40.08 | ₹711.29 8.61 USD | ||
| Grifols, S.A. G0FB.F | €7.60 8.31 USD |
-1.3
|
€6.60B 7.22B USD | €55.00 60.12 USD | €7.60 8.31 USD | €7.60 8.31 USD | €6.60B 7.22B USD | 13.81 | €0.55 0.6 USD | ||
| Ono Pharmaceutical OPHLF | $12.87 — |
0
|
$6.24B — | $104.00 — | $12.22 — | $12.22 — | $6.24B — | 17.87 | $0.72 — | ||
| Ono Pharmaceutical Co., Ltd. ON4.MU | €11.60 12.68 USD |
-1.69
|
€5.53B 6.05B USD | €0.00 0 USD | €11.60 12.68 USD | €11.80 12.9 USD | €5.53B 6.05B USD | 19.01 | €0.61 0.67 USD | ||
| Ono Pharmaceutical Co., Ltd. ON4.F | €12.30 12.57 USD |
+0.82
|
€5.48B 5.99B USD | €41.00 44.82 USD | €11.50 12.57 USD | €11.50 12.57 USD | €5.48B 5.99B USD | 18.85 | €0.61 0.67 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,375.00 28.91 USD |
-3.52
|
₹404.77B 4.9B USD | ₹1.83K 115.62 USD | ₹2,364.10 28.6 USD | ₹2,465.80 29.83 USD | ₹404.77B 4.9B USD | 42.31 | ₹56.47 0.68 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,384.20 28.84 USD |
-3.76
|
₹403.90B 4.89B USD | ₹517.48K 6.26K USD | ₹2,362.60 28.58 USD | ₹2,468.40 29.86 USD | ₹403.90B 4.89B USD | 42.21 | ₹56.48 0.68 USD | ||
| PT Kalbe Farma Tbk PTKFF | $0.07 — |
0
|
$3.54B — | $185.00K — | $0.08 — | $0.08 — | $3.54B — | 0 | $0.00 — | ||
| Gland Pharma Limited GLAND.NS | ₹1,667.70 20.18 USD |
+1.07
|
₹274.76B 3.32B USD | ₹160.29K 1.94K USD | ₹1,631.10 19.73 USD | ₹1,684.90 20.38 USD | ₹274.76B 3.32B USD | 34.72 | ₹48.02 0.58 USD | ||
| Virbac SA 0NM7.IL | €355.75 389.98 USD |
0
|
€3.04B 3.32B USD | €828.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.04B 3.32B USD | 25.50 | €13.99 15.29 USD | ||
| Gland Pharma Limited GLAND.BO | ₹1,679.80 20.15 USD |
+0.93
|
₹274.35B 3.32B USD | ₹2.21K 71.11 USD | ₹1,631.10 19.73 USD | ₹1,678.10 20.3 USD | ₹274.35B 3.32B USD | 34.68 | ₹48.01 0.58 USD | ||
| Virbac SA VIRP.PA | €356.50 389.7 USD |
-0.42
|
€2.99B 3.26B USD | €1.77K 1.94K USD | €352.50 385.33 USD | €357.50 390.8 USD | €2.99B 3.26B USD | 22.42 | €15.90 17.38 USD | ||
| Virbac SA V16.F | €348.50 380.96 USD |
-0.29
|
€2.92B 3.19B USD | €2.00 2.19 USD | €348.50 380.96 USD | €351.00 383.69 USD | €2.92B 3.19B USD | 21.95 | €15.87 17.35 USD | ||
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.70 9.51 USD |
0
|
€2.80B 3.06B USD | €23.00 25.14 USD | €8.70 9.51 USD | €8.70 9.51 USD | €2.80B 3.06B USD | 17.39 | €0.50 0.55 USD | ||
| Santen Pharmaceutical SNPHF | $9.51 — |
0
|
$3.06B — | $200.00 — | $12.46 — | $12.64 — | $3.06B — | 16.11 | $0.59 — | ||
| Haw Par Corporation Limited HAWPY | $49.03 — |
0
|
$2.81B — | $1.00 — | $46.37 — | $46.37 — | $2.81B — | 14.63 | $3.47 — | ||
| Pfizer Limited PFIZER.BO | ₹4,848.00 59.63 USD |
+0.86
|
₹225.73B 2.73B USD | ₹757.00 12.29 USD | ₹4,863.30 58.84 USD | ₹5,000.55 60.5 USD | ₹225.73B 2.73B USD | 26.87 | ₹183.40 2.22 USD | ||
| Pfizer Limited PFIZER.NS | ₹4,926.60 59.6 USD |
-0.66
|
₹225.38B 2.73B USD | ₹66.30K 802.17 USD | ₹4,855.20 58.74 USD | ₹5,005.60 60.56 USD | ₹225.38B 2.73B USD | 26.84 | ₹183.49 2.22 USD | ||
| Haw Par HAWPF | $12.23 — |
0
|
$2.71B — | $100.00 — | $12.23 — | $12.23 — | $2.71B — | 13.89 | $0.88 — | ||
| Cosmo Pharmaceuticals CMOPF | $136.30 — |
+2.91
|
$2.41B — | $100.00 — | $136.00 — | $136.00 — | $2.41B — | 32.23 | $4.21 — | ||
| Johnson & Johnson DJNJ2.BA | ARS 815.00 0.96 USD |
0
|
ARS 1.96T 2.32B USD | ARS 0.00 0 USD | ARS 815.00 0.96 USD | ARS 815.00 0.96 USD | ARS 1.96T 2.32B USD | 13.25 | ARS 61.49 0.07 USD | ||
| Cosmo Pharmaceuticals N.V. C43.F | €113.00 123.52 USD |
-1.74
|
€1.82B 1.99B USD | €270.00 295.15 USD | €113.00 123.52 USD | €113.00 123.52 USD | €1.82B 1.99B USD | 31.65 | €3.57 3.9 USD | ||
| Organon & Co. OGN.MX | MX$128.00 7.58 USD |
+1.13
|
MX$33.28B 1.97B USD | MX$10.00 0.59 USD | MX$128.00 7.58 USD | MX$128.00 7.58 USD | MX$33.28B 1.97B USD | 3.74 | MX$34.20 2.03 USD | ||
| Organon & Co. 7XP.F | €6.02 6.58 USD |
+0.07
|
€1.56B 1.71B USD | €367.00 401.18 USD | €5.97 6.53 USD | €6.02 6.58 USD | €1.56B 1.71B USD | 3.71 | €1.62 1.77 USD | ||
|
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
|||||||||||
- {{ link.label }} {{link}}